NSAIDs and cognition in Alzheimer's disease

Neurology

Volumn 46, Issue 4, 1996, Pages 1194-

  Doraiswamy, P Murali ^a   Krishen, Alok ^a   Stallone, Frank ^a   Martin, Wendy L ^a   Potts, Nicholas L S ^a   Metz, Alan ^a   DeVeaugh Geiss, Joseph ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; DRUG EFFECT; FEMALE; HUMAN; LETTER; MALE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COGNITION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS;

EID: 0030118135     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.46.4.1194     Document Type: Letter

References (5)

1. Anderson K, Launer LJ, Ott A, et al. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995;45:1441-1445.
2. The Canadian Study of Health and Aging Investigators. Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
3. Breitner JCS, Gau BA. Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Initial results of a co-twin control study. Neurology 1994;44:227-232.
4. Masaki KH, White LR. Petrovich H, et al. The influence of prior and concurrent use of aspirin and vitamins on cognitive function scores in elderly Japanese-American men (abstract). Fourth International Conference on Alzheimer's Disease and Related Disorders. Neurobiology of Aging 1994:15(S1).
5. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:11,1356-1364.